| Dr Kimberly Ann Layfield, OD | |
|
12255 Depaul Drive, Suite 360, Bridgeton, MO 63044-2510 | |
| (314) 739-9293 | |
| (314) 739-3968 |
| Full Name | Dr Kimberly Ann Layfield |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 12255 Depaul Drive, Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407054943 | NPI | - | NPPES |
| 317423705 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2007018394 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comprehensive Eye Care And Surgery Inc | 3577504471 | 2 |
News Archive
A genetic mutation can significantly increases a woman's risk of developing breast cancer and ovarian cancer. But does that mean everyone should be tested?
A newly published study of people with chronic obstructive pulmonary disease (COPD) concludes that long-term supplemental oxygen treatment results in little or no change in time to death, time to first hospitalizations or significant quality of life improvements for those with moderately low blood oxygen levels.
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.
› Verified 1 days ago
| Provider Name | Comprehensive Eye Care And Surgery Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417065129 PECOS PAC ID: 3577504471 Enrollment ID: O20050520000739 |
News Archive
A genetic mutation can significantly increases a woman's risk of developing breast cancer and ovarian cancer. But does that mean everyone should be tested?
A newly published study of people with chronic obstructive pulmonary disease (COPD) concludes that long-term supplemental oxygen treatment results in little or no change in time to death, time to first hospitalizations or significant quality of life improvements for those with moderately low blood oxygen levels.
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Ann Layfield, OD 262 Valleybrook Ct, O Fallon, MO 63368-9638 Ph: (314) 956-7227 | Dr Kimberly Ann Layfield, OD 12255 Depaul Drive, Suite 360, Bridgeton, MO 63044-2510 Ph: (314) 739-9293 |
News Archive
A genetic mutation can significantly increases a woman's risk of developing breast cancer and ovarian cancer. But does that mean everyone should be tested?
A newly published study of people with chronic obstructive pulmonary disease (COPD) concludes that long-term supplemental oxygen treatment results in little or no change in time to death, time to first hospitalizations or significant quality of life improvements for those with moderately low blood oxygen levels.
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.
› Verified 1 days ago
Crescent Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12110 Saint Charles Rock Rd, Bridgeton, MO 63044 Phone: 314-291-3700 Fax: 314-291-3708 | |
Kursar Eyecare, Ltd. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3454 Mckelvey Rd, Bridgeton, MO 63044 Phone: 314-291-7717 Fax: 314-291-7372 | |
Dr. Tareq I. Nabhan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12110 Saint Charles Rock Rd, Bridgeton, MO 63044 Phone: 314-291-3700 | |
Crown Optical Optometrist Medicare: Medicare Enrolled Practice Location: 3454 Mckelvey Rd, Bridgeton, MO 63044 Phone: 314-291-7717 Fax: 314-291-7372 |